Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
H.R. 1375 (118th Congress)
H.R. 1375 is a bill of the 118th Congress (2023–2025), in committee as of 2023-03-03; sponsored by David J. Trone and 5 others.
https://ontology.bommaritollc.com/id/01a10f0f-aafc-77fa-a3d0-3c2bc4268376
Elsewhere
Official pagewww.govinfo.gov
Sourcewww.govinfo.gov
Facts
| adms:identifier | |
| dcterms:date | 2023-03-03xsd:date |
| dcterms:temporal | |
| eli:title_short | EFFECTIVE Acten Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Acten |
| in committee | |
| primary sponsor | |
| prov:wasDerivedFrom | |
| schema:legislationIdentifier | H.R. 1375 |
| schema:legislationJurisdiction | |
| schema:legislationType | |
| schema:name | EFFECTIVE Acten |
| schema:sponsor | |
| schema:url | |
| skos:prefLabel | H.R. 1375 (118th Congress)en |
| status | |
| status date | 2023-03-03xsd:date |